Regulation of Lung Inflammation by Local Glucocorticoid Metabolism: An Hypothesis

References

• Funder J W, Pierce F T, Smith R, Smith A I. Mineralocortiooid action: target tissue specificity is enzyme, not receptor, mediated. Science 1988; 242: 583–585
   PubMed Web of Science ®Google Scholar
• Edwards C RW, Burt D, McIntyre M A, Kloet E R, Stewart P M, Brett L, Sutanto W S, Monder C. Localisation of 11β-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet 1988; 1: 986–989
   Google Scholar
• Monder C, Stewart P M, Lakshmi V, Valentino R, Burt D, Edwards C RW. Licorice inhibits corticosteroid 11β-dehydrogenase of rat kidney and liver: In vivo and In vitro studies. Endocrinology 1989; 125: 1046–1053
   PubMed Web of Science ®Google Scholar
• Schleimer R P. Metabolism of hydrocortisone in human lung by 11β-hydroxysteroid dehydrogenase (HSD). Tissue distribution and blockade of the enzyme by glycyrrhetinic acid and carbenoxolone. FASEB J 1990; 4: A453
   Google Scholar
• Peterson R E, Pierce C E, Wyngaarden J M, Bunim J J, Brodie B B. The physiological disposition and metabolic fate of cortisone in man. J Clin Invest 1957; 36: 1301–1312
   Google Scholar
• Berliner D L, Dougherty T F. Metabolism of cortisol by loose connective tissue in vitro. PSEBM 1958; 98: 3–6
   Google Scholar
• Mahesh V B, Ulrich F. Metabolism of cortisol and cortisone by various tissues and subcellular particles. J Biol Chem 1960; 235: 356–360
   Google Scholar
• Kowarski A, Lawrence B, Hung W, Migeon C J. Interconversion of cortisol and cortisone in man and its effect on the measurement of cortisol secretion rate. J Clin Endocr 1969; 29: 377–381
   Google Scholar
• Bush I E. Chemical and biological factors in the activity of adrenocortical steroids. Pharm Rev 1962; 14: 317–445
   PubMed Web of Science ®Google Scholar
• Berliner D L, Dougherty T F. Influence of reticuloendothelial and other cells on the metabolic fate of steroids. Ann NY Acad Sci 1960; 88: 14–29
   Web of Science ®Google Scholar
• Meigs R A, Engel L L. The metabolism of adrenocortical steroids by human tissues. Endocrinology 1961; 69: 152–162
   Google Scholar
• Bush I E, Hunter S A, Meigs R A. Metabolism of 11-oxygenated steroids. Biochem J 1968; 107: 239–258
   PubMed Web of Science ®Google Scholar
• Sweat M L, Bryson M J. The role of phosphopyridine-nucleotides in the metabolism of cortisol by peripheral tissue. Biochim Biophys Acta 1960; 44: 211–223
   Google Scholar
• Pearson Murphy B E. Ontogeny of cortisol-cortisone interconversion in human tissues: A role for cortisone in human fetal development. J Ster Biochem 1981; 14: 811–817
   Google Scholar
• Monder C. Characterization and biological significance of corticosteroid 11β-dehydrogenase, the oxidizing component of 11β-hydroxysteroid dehydrogenase. Ann NY Acad Sci 1990; 595: 26–39
   PubMedGoogle Scholar
• Monder C, Shackleton C HL. 11β-hydroxysteroid dehydrogenase: Fact or fancy?. Steroids 1984; 44: 383–417
   PubMed Web of Science ®Google Scholar
• Abramovitz M, Branchaud C L, Murphy B EP. Cortisol-cortisone interconversion in human fetal lung: contrasting results using explant and monolayer cultures suggest 11β-hydroxysteroid dehydrogenase (EC 1.1.1.146) comprises two enzymes. J Clin Endocrinol Metab 1982; 54: 563–568
   PubMed Web of Science ®Google Scholar
• Smith B T. The role of pulmonary corticosteroid 11-reductase activity in lung maturation in the fetal rat. Pediatr Res 1978; 12: 12–14
   PubMed Web of Science ®Google Scholar
• Schleimer R P. Potential regulation of inflammation in the lung by local metabolism of hydrocortisone. Am J Respir Cell Mol Biol 1991; 4: 166–173
   PubMed Web of Science ®Google Scholar
• Pearson Murphy B E. Specificity of human 11β-hydroxysteroid dehydrogenase. J Ster Biochem 1981; 14: 807–809
   Google Scholar
• Ulick S, Levin L S, Gunczler P, Zanconato G, Ramirez L C, Rauh W, Rosier A, Bradlow H L, New M I. A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J Clin Endocrinol Metab 1979; 49: 757–764
   PubMed Web of Science ®Google Scholar
• Abramovitz M, Carriero R, Pearson Murphy B E. Investigation of factors influencing 11β-hydroxysteroid dehydrogenase (EC 1.1.1.146) activity in midgestational human fetal lung monolayer and explant cultures. J Ster Biochem 1984; 21: 677–683
   Google Scholar
• Lakshmi V, Monder C. Purification and characterization of the corticosteroid 11β-dehydrogenase component of the rat liver 11β-hydroxysteroid dehydrogenase complex. Endocrinology 1988; 123: 2390–2398
   PubMed Web of Science ®Google Scholar
• Lakshmi V, Monder C. Evidence for independent 11-oxidase and 11-reductase activities of 11β-hydroxysteroid dehydrogenase: Enzyme latency, phase transitions, and lipid requirements. Endocrinology 1985; 116: 552–560
   PubMedGoogle Scholar
• Agarwal A K, Monder C, Eckstein B, White P C. Cloning and expression of rat cDNA encoding corticosteroid 11β-dehydrogenase. J Biol Chem 1989; 264: 18939–18943
   PubMed Web of Science ®Google Scholar
• Adamson A C, Tillman W G. Hydrocortisone. Br Med J 1955; 17: 1501
   Google Scholar
• Colin-Jones E. Glycyrrhetinic acid. Br Med J 1957; 19: 161
   Google Scholar
• Sommerville J. Glycyrrhetinic acid. Br Med J 1957; 2: 282–283
   Google Scholar
• Gillies Annan W. Hydrocortisone and glycyrrhetinic acid. Br Med J 1957; 25: 1242
   Google Scholar
• Doll R, Hill I D, Hutton C, Underwood I DJ. Clinical trial of a triterpenoid liquorice compound in gastric and duodenal ulcer. Lancet 1962; 2: 793–796
   Web of Science ®Google Scholar
• Persson C GA. Glucocorticoids for asthma-early contributions. Pulmon Pharmacol 1989; 2: 163–166
   Google Scholar
• Sircus W. Carbenoxolone sodium. Gut, 13: 816–824, 172
   Google Scholar
• Shibata S, Takahashi K, Yano S, Harada M, Saito H, Tamura Y, Kumagai A, Hirabayashi K, Yamamoto M, Nagata N. Chemical modification of glycyrrhetinic acid in relation to the biological activities. Chem Pharm Bull 1987; 35: 1910–1918
   Google Scholar
• Abe H, Ohya N, Fujikawa Yamamoto K, Shibuya T, Arichi S, Odashima S. Effects of glycyrrhizin and glycyrrhetinic acid on growth and melanogenesis in cultured B16 melanoma cells. Eur J Cancer Clin Oncol 1987; 23: 1549–1555
   PubMedGoogle Scholar
• Davidson J S, Baumgarten I M, Harley E H. Reversible inhibition of intercellular junctional communication by glycyrrhetinic acid. Biochem Biophys Res Commun 1986; 134: 29–36
   PubMed Web of Science ®Google Scholar
• Tamaya T, Sato S, Okada H H. Possible mechanism of steroid action of the plant herb extracts glycyrrhizin, glycyrrhetinic acid, and paeoniflorin: Inhibition by plant herb extracts of steroid protein binding in the rabbit. Am J Obstet Gynecol 1986; 155: 1134–1139
   PubMed Web of Science ®Google Scholar
• Valentino R, Stewart P M, Burt D, Edwards C RW. Liquorice inhibits 11 beta hydroxysteroid dehydrogenase in the rat. J Endocrinol 1987; 112: 260
   Google Scholar
• Stewart P M, Valentino R, Wallace A M, Burt D, Shackleton C HL, Edwards C RW. Mineralocorticoid activity in liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age. Lancet 1987; 1: 821–824
   Google Scholar
• Mackenzie M A, Hoefnagels W HL, Jansen R WMM, Benraad T J, Kloppenborg W C. The influence of glycyrrhetinic acid on plasma cortisol and cortisone in healthy young volunteers. J Clin Endocrinol Metab 1990; 70: 1637–1643
   PubMed Web of Science ®Google Scholar
• Osinski P A. Steroid 11β-ol dehydrogenase in human placenta. Nature 1960; 27: 777
   Google Scholar
• Giroud C JP. Aspects of corticosteroid biogenesis and metabolism during the perinatal period. Clin Obstet Gynecol 1971; 14: 745–762
   PubMedGoogle Scholar
• Pearson Murphy B E, Clark S J, Donald I R, Pinsky M, Vedady D. Conversion of maternal cortisol to cortisone during placental transfer to the human fetus. Am J Obstet Gynecol 1973; 118: 538–541
   Google Scholar
• Beitins I Z, Bayard F, Ances I G, Kowardski A, Migeon C J. The transplacental passage of prednisone and prednisolone in pregnancy near term. J Pediatr 1972; 81: 936–945
   PubMed Web of Science ®Google Scholar
• Pearson Murphy B E, Diez d'Aux R C. Steroid levels in the human fetus: cortisol and cortisone. J Clin Endocrinol Metab 1972; 35: 678–683
   Google Scholar
• Pearson Murphy B E. Does the human fetal adrenal play a role in parturition?. Am J Obstet Gynecol 1972; 115: 521–525
   Google Scholar
• Challis J RG, Thorburn G D. Prenatal endocrine function and the initiation of parturition. Br Med Bull 1975; 31: 57–61
   Google Scholar
• Pearson Murphy B E. Chorionic membrane as an extra-adrenal source of feotal cortisol in human amniotic fluid. Nature 1977; 266: 179–181
   Google Scholar
• Axelrod L. Side effects of glucocorticoid therapy. Antiinflammatory Steroid Action. Basic and Clinical Aspects, R P Schleimer, H N Claman, A R Oronsky. Academic Press, San Diego 1989; 377–408
   Google Scholar
• Pearson Murphy B E. Conversion of cortisol to cortisone by the human uterus and its reversal in pregnancy. J Clin Endocrinol Metab 1977; 44: 1214–1217
   Google Scholar
• Bernal A L, Flint A PF, Anderson A BM, Turnbull A C. 11β-hydroxysteroid dehydrogenase activity (E.C. 1.1.1.146) in human placenta and decidua. J Ster Biochem 1980; 13: 1081–1087
   Google Scholar
• Ganis F M, Axelrod L R, Miller L L. The metabolism of hydrocortisone by kidney tissue in vitro. J Biol Chem 1955; 218: 841–848
   Google Scholar
• Hellman L, Nakada F, Zumoff B, Fukushima D, Bradlow H L, Gallagher T F. Renal capture and oxidation of cortisol in man. J Clin Endocr 1971; 33: 52–62
   Google Scholar
• Ulick S, Levine L S, Gunczler P, Zanconato G, Ramirez L C, Rauh W, Rosier A, Bradlow H L, New M I. A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J Clin Endocrinol Metabol 1979; 49: 757–764
   PubMed Web of Science ®Google Scholar
• Oberfield S E, Levine L S, Carey R M, Greig F, Ulick S, New M I. Metabolic and blood pressure responses to hydrocortisone in the syndrome of apparent mineralocorticoid excess. J Clin Endocrinol Metab 1983; 56: 332–339
   PubMed Web of Science ®Google Scholar
• Phillipou C, Higgins B A. A new defect in the peripheral conversion of cortisone to cortisol. J Ster Biochem 1985; 22: 435–436
   PubMedGoogle Scholar
• Monder C, Shackleton C H, Bradlow H L, New M I, Stoner E, Iohan F, Lakshmi V. The syndrome of apparent mineralocorticoid excess: Its association with 11β-dehydrogenase and 5β-reductase deficiency and some consequences for corticosteroid metabolism. J Clin Endocrinol Metab 1986; 63: 550–557
   PubMed Web of Science ®Google Scholar
• Stewart P M, Corrie J ET, Shackleton C HL, Edwards C RW. Syndrome of apparent mineralocorticoid excess. J Clin Invest 1988; 82: 340–349
   PubMed Web of Science ®Google Scholar
• Krozowski Z S, Funder J W. Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity. Proc Natl Acad Sci (USA) 1983; 80: 6056–6060
   PubMed Web of Science ®Google Scholar
• Arriza J L, Weinberger C, Cerelli G, Glaser T M, Handelin B L, Housman D E, Evans R M. Cloning of human mineralocorticoid receptor complementary DNA: Structure and functional kinship with the glucocorticoid receptor. Science 1987; 237: 268–275
   PubMed Web of Science ®Google Scholar
• Molhuysen J A, Gerbrandy J, De Vries L A, De Jong J C, Lenstra J B, Turner K P, Borst J GG. A liquorice extract with deoxycortisone-like action. Lancet 1950; 2: 381–386
   PubMedGoogle Scholar
• Borst J GG, De Vries L A, Ten Holt S P, Molhuysen J A. Synergistic action of liquorice and cortisone in Addison's and Simmonds's disease. Lancet 1953; 1: 657–663
   Google Scholar
• Card W I, Mitchell W, Strong J A, Taylor N RW, Tompsett S L, Wilson J MG. Effects of liquorice and its derivatives on salt and water metabolism. Lancet 1953; 663–668
   Google Scholar
• Malkinson F D, Lee M W, Cutukovic Con I. In vitro studies of adrenal steroid metabolism in the skin. J Inv Derm 1959; 32: 101–107
   PubMed Web of Science ®Google Scholar
• Hsia S L, Hao Y-L. Metabolic transformations of cortisol-4-[14C] in human skin. Biochemistry 1966; 5: 1469–1474
   PubMed Web of Science ®Google Scholar
• Teelucksingh S, Mackie A DR, Burt D, McIntyre M A, Brett L, Edwards C RW. Potentiation of hydrocortisone activity in skin by glycyrrhetinic acid. Lancet 1990; 2: 1060–1063
   Google Scholar
• Imanishi N, Ohmori E, Yatsunami K, Ichikawa A. Effect of hydrocortisone on histidine decarboxylase activity in rat stomach. Chem Pharm Bull 1988; 36: 4088–4094
   Google Scholar
• Gluck L, Kulovich M V, Borer R CJ, Brenner P H, Anderson G G, Spellacy W N. Diagnosis of the respiratory distress syndrome by amniocenteses. Am J Obstet Gynecol 1971; 109: 440–445
   PubMed Web of Science ®Google Scholar
• Whitfield C R, Chan W H, Sproule W B, Stewart A D. Amniotic fluid lecithin: Sphingomyelin ratio and fetal lung development. Br Med J 1972; 8: 85–86
   Google Scholar
• Pearson Murphy B E. Cortisol and cortisone levels in the cord blood at delivery of infants with and without the respiratory distress syndrome. Am J Obstet Gynecol 1974; 119: 1112–1120
   Google Scholar
• Pearson Murphy B E. Evidence of cortisol deficiency at birth in infants with the respiratory distress syndrome. J Clin Endocrinol Metab 1974; 38: 158
   Google Scholar
• Sybulski S, Maughan G B. Relationship between cortisol levels in umbilical cord plasma and development of the respiratory distress syndrome in premature newborn infants. Am J Obstet Gynecol 1975; 725: 239–243
   Google Scholar
• Sharp-Cageorge S M, Blicher B M, Gordon E R, Pearson Murphy B E. Amniotic-fluid cortisol and human fetal lung maturation. N Engl J Med 1977; 296: 89–92
   Google Scholar
• Smith B T, Worthington D, Piercy W N. The relationship of cortisol and cortisone to saturated lecithin concentration in ovine amniotic fluid and fetal lung liquid. Endocrinology 1977; 101: 104–109
   Google Scholar
• Spellacy W N, Buhi W C, Riggall F C, Holsinger K L. Human amniotic fluid lecithin/sphingomyelin ratio changes with estrogen or glucocorticoid treatment. Am J Obstet Gynecol 1972; 115: 216–218
   Google Scholar
• Liggins G C, Howie R N. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972; 50: 515–525
   PubMed Web of Science ®Google Scholar
• Farrell P M, Zachman R D. Induction of choline phosphotransferase and lecithin synthesis in the fetal lung by corticosteroids. Science 1973; 119: 297–298
   Google Scholar
• Smith B T, Torday J S, Giroud C JP. The growth promoting effect of cortisol on human fetal lung cells. Steroids 1973; 22: 515–524
   Google Scholar
• Torday J S, Smith B T, Giroud C JP. The rabbit fetal lung as a glucocorticoid target tissue. Endocrinology 1975; 96: 1462–1467
   PubMed Web of Science ®Google Scholar
• Giannopoulos G, Mulay S, Solomon S. Cortisol receptors in rabbit fetal lung. Biochem Biophys Res Commun 1972; 47: 411–418
   PubMed Web of Science ®Google Scholar
• Ballard P L, Ballard R A. Glucocorticoid receptors and the role of glucocorticoids in fetal lung development. Proc Natl Acad Sci (USA) 1972; 69: 2668–2672
   PubMed Web of Science ®Google Scholar
• Giannapoulos G. Variations of the levels of cytoplasmic glucocorticoid receptors in lungs of various species at different developmental stages. Endocrinology 1974; 94: 450–458
   Google Scholar
• Ballard P L, Ballard R A. Cytoplasmic receptor for glucocorticoids in lung of the human fetus and neonate. J Clin Invest 1974; 53: 477–486
   PubMed Web of Science ®Google Scholar
• Pearson Murphy B E. Cortisol and cortisone in human fetal development. J Steroid Biochem 1979; 11: 509–513
   Google Scholar
• Cullen J J, Welsh M J. Regulation of sodium absorption by canine tracheal epithelium. J Clin Invest 1987; 79: 73–79
   PubMed Web of Science ®Google Scholar
• Vichyanond P, Irvin C G, Larsen G L, Szefler S J, Hill M R. Penetration of corticosteroids into the lung: Evidence for a difference between methylpred-nisolone and prednisolone. J Allergy Clin Immunol 1989; 84: 867–873
   Google Scholar
• Csonka G W, Murray M. Clinical evaluation of carbenoxolone in balanitis. Br J Vener Dis 1971; 47: 179–181
   Google Scholar
• Davies W A, Reed P I. Controlled trial of duogastrone in duodenal ulcer. Gut 1977; 18: 78–83
   Google Scholar
• Yaginuma T, Izumi R, Yasui H, Arai T, Kawabata M. Effect of traditional herbal medicine on serum testosterone levels and its induction of regular ovulation in hyperandrogenic and oligomenorrheic women. Acta Obstet Gynaecol Jpn 1982; 34: 939–944
   Google Scholar
• Boström H, Bernsten K, Whitehouse M W. Biochemical properties of anti-inflammatory drugs-II. Biochem Pharmacol 1964; 13: 413–420
   PubMed Web of Science ®Google Scholar
• Finney R SH, Tárnoky A L. The pharmacological properties of glycyrrhetinic acid hydrogen succinate. J Pharm Pharmacol 1960; 12: 49–58
   Google Scholar
• Finney R SH, Tárnoky A L. The pharmacological properties of glycyrrhetinic acid hydrogen succinate (disodium salt). J Pharm Pharmacol 1959; 12: 49–58
   Google Scholar
• Finney R SH, Somers G F. The anti-inflammatory activity of glycyrrhetinic acid and derivatives. J Pharm Pharmacol 1958; 10: 613–620
   PubMed Web of Science ®Google Scholar
• Capasso F, Mascolo N, Autore G, Duraccio M R. Glycyrrhetinic acid, leucocytes and prostaglandins. J Pharm Pharmacol 1983; 35: 332–335
   Google Scholar
• Kumagai A, Yano S, Takeuchi K, Nishino K, Asanuma Y, Nanaboshi M, Yamamura Y. An inhibitory effect of glycyrrhinizin on the anti-granulomatous action of cortisone. Endocrinology 1964; 74: 145–148
   Google Scholar
• Tangri K K, Seth P K, Parmar S S, Bhargava K P. Biochemical study of anti-inflammatory and antiarthritic properties of glycyrrhetic acid. Biochem Pharmacol 1965; 14: 1277–1281
   Google Scholar
• Inoue H, Mori T, Shibata S, Koshihara Y. Modulation by glycyrrhetinic acid derivatives of TPA-induced mouse ear edema. Br J Pharmacol 1989; 96: 204–210
   PubMed Web of Science ®Google Scholar
• Inoue H, Mori T, Shibata S, Koshihara Y. Inhibitory effect of glycyrrhetinic acid derivatives on arachidonic acid-induced mouse ear edema. J Pharm Pharmacol 1988; 40: 272–277
   PubMed Web of Science ®Google Scholar
• Inoue H, Mori T, Shibata S, Saito H. Pharmacological activities of glycyrrhetinic acid derivatives: Analgesic and anti-type IV allergic effects. Chem Pharm Bull 1987; 35: 3888–3893
   PubMed Web of Science ®Google Scholar
• Inoue H, Kurosu S, Takeuchi T, Mori T, Shibata S. Glycyrrhetinic acid derivatives: anti-nociceptive activity of deoxoglycyrrhetol dihemiphthalate and the related compounds. J Pharm Pharmacol 1990; 42: 199–200
   Google Scholar
• Nishino H, Nishino A, Takayasu J, Hasegawa T, Iwashima A, Hirabayashi K, Iwata S, Shibata S. Inhibition of the tumor-promoting action of 12–0-tetradecanoylphorbol-13-acetate by some oleanane-type triterpenoid compounds. Cancer Res 1988; 48: 5210–5215
   PubMedGoogle Scholar
• Yano S, Harada M, Watanabe K, Nakamaru K, Hatakeyama Y, Shibata S, Takahashi K, Mori T, Hirabayashi K, Takeda M, Nagata N. Antiulcer activities of glycyrrhetinic acid derivatives in experimental gastric lesion models. Chem Pharm Bull 1989; 37: 2500–2504
   Google Scholar
• Atherden L M. Studies with glycyrrhetic acid: Inhibition of metabolism of steroids in vitro. Biochem J 1958; 69: 75–78
   PubMed Web of Science ®Google Scholar
• Ohtsuki K, Ishida N. Inhibitory effect of glycyrrhizin on polypeptide phosphorylation by polypeptide-dependent protein kinase (kinase P) in vitro. Biochem Biophys Res Commun 1988; 57: 597–604
   Google Scholar
• Baba M, Shigeta S. Antiviral activity of glycyrrhizin against varicella-zoster virus in vitro. Antiviral Res 1987; 7: 99–107
   PubMed Web of Science ®Google Scholar
• Ito M, Nakashima H, Baba M, Pauwels R, De Clercq E, Shigeta S, Yamamoto N. Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus [HIV HTLV-III/LAV)]. Antiviral Res 1987; 7: 127–137
   PubMed Web of Science ®Google Scholar
• Pompei R, Flore O, Marccialis M A, Pani A, Loddo B. Glycyrrhizic acid inhibits virus growth and inactivates virus particles. Nature 1979; 287: 689–690
   Google Scholar
• Shinada M, Azuma M, Kawai H, Sazaki K, Yoshida I, Yoshida T, Suzutani T, Sakuma T. Enhancement of interferon-7 production in glycyrrhizin-treated human peripheral lymphocytes in response to con-canavalin A and to surface antigen to hepatitis B virus (42241). Soc Exp Biol Med 1986; 181: 205–210
   PubMed Web of Science ®Google Scholar
• Ohuchi K, Kamada Y, Levine L, Tsurufuji S. Glycyrrhizin inhibits prostaglandin E2 production by activated peritoneal macrophages from rats. Prostaglandins Med 1986; 7: 457–463
   Google Scholar
• Imanishi N, Kawai H, Hayashi Y, Yatsunami K, Ichikawa A. Effects of glycyrrhizin and glycyrrhetinic acid on dexamethasone-induced changes in histamine synthesis of mouse mastocytoma P-815 cells and in histamine release from rat peritoneal mast cells. Biochem Pharmac 1989; 38: 2521–2526
   Google Scholar
• Inoue H, Saito H, Koshihara Y, Murota S. Inhibitory effect of glycyrrhetinic acid derivatives on lipoxygenase and prostaglandin synthetase. Chem Pharm Bull 1986; 34: 897–901
   PubMed Web of Science ®Google Scholar